VERTEX PHARMAC. DL-,01/ US92532F1003 /
9/20/2024 9:38:18 PM | Chg. -11.950 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
416.000EUR | -2.79% | 42 Turnover: 17,801 |
-Bid Size: - | -Ask Size: - | 107.48 bill.EUR | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 14.05 USD | 8.33% |
EPS Diluted: | 13.89 USD | 8.35% |
Revenues per Share: | 38.21 USD | 9.99% |
Book Value per Share: | 68.06 USD | 25.77% |
Cash Flow per Share: | 13.69 USD | -14.75% |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 9,869.20 USD | 10.51% |
Net Income: | 3,619.60 USD | 8.96% |
Operating Cash Flow: | 3,537.30 USD | - |
Cash and Cash Equivalents: | 10,369.10 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 33.09 | 28.96 |
P/S Ratio: | 12.17 | 10.65 |
P/BV ratio: | 6.83 | 5.98 |
P/CF Ratio: | 33.95 | 29.71 |
PEG: | 3.97 | 3.48 |
Earnings Yield: | 3.02% | 3.45% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 107.48 bill. EUR | 95.19 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | - EUR | - EUR |
Shares Outstanding: | 258.1 mill. |
Profitability
Gross Profit Margin: | 87.21% |
EBIT Margin: | 38.83% |
Net Profit Margin: | 36.68% |
Return on Equity: | 20.59% |
Return on Assets: | 15.92% |
Financial Strength
Liquidity I / Cash Ratio: | 2.92% |
Liquidity II / Quick Ratio: | 3.36% |
Liquidity III / Current Ratio: | 3.99% |
Debt / Equity Ratio: | 0.02% |
Dynam. Debt / Equity Ratio: | 145.59% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 12/31/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |